Dr. Matthew T. Oliver, MD
- Medicare services, 2024
- 155
- Medicare patients, 2024
- 98
- Part D claims, 2024
- 66
- Publications
- 10
- Clinical trials
- 4
- Practice address
- 101 Dudley Street, Providence, RI 02905
- Practice phone
- Call (401) 274-1100
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Oliver's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Matthew T. Oliver is a gynecologic oncologist in Providence, Rhode Island
Dr. Oliver practices at Women & Infants Hospital of Rhode Island in Providence, Rhode Island, part of Care New England Health System.
Dr. Oliver's NPI, 1295028611, was assigned on May 18, 2011. Dr. Oliver graduated from East Tennessee State University Quillen College of Medicine in 2011. Dr. Oliver holds Rhode Island license MD14914.
- NPI
- 1295028611NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4284920125
- NPI enumeration date
- May 18, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (401) 274-1100
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Matthew T. Oliver practices at Women & Infants Hospital of Rhode Island in Providence, Rhode Island
Dr. Oliver's primary practice is Women & Infants Hospital of Rhode Island, at 101 Dudley Street, Providence, RI 02905 in Providence County. The practice phone is (401) 274-1100.
- Women & Infants Hospital of Rhode Island101 Dudley Street, Providence, RI 02905 · Providence CountyPhone(401) 274-1100
Source: Dmand AI Affiliation Data
Dr. Matthew T. Oliver is affiliated with 4 sites of care and 2 medical groups
Dr. Oliver's primary practice is Women & Infants Hospital of Rhode Island in Providence, Rhode Island, part of Care New England Health System. Dr. Oliver is also affiliated with Charlton Memorial Hospital. The medical group on file is Care New England Medical Group. Dmand AI also links Dr. Oliver to 2 more hospitals and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Matthew T. Oliver's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oliver practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Women & Infants Hospital of Rhode Island | Available with a free account |
| +3 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Care New England Health System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Matthew T. Oliver is one of 10 gynecologic oncologists in Rhode Island
Gynecologic oncology is Dr. Oliver's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Oliver's licenses on file in 2 states: Rhode Island and Massachusetts.
Specialties and state licenses
- Gynecologic oncology, Rhode IslandPrimary
- Massachusetts license
Gynecologic oncologists near Dr. Oliver
Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Matthew T. Oliver billed Medicare for 155 services in 2024
CMS data shows 155 Medicare services from Dr. Oliver across 4 procedure codes in 2024, for 98 Medicare patients. Medicare paid $11,101 for them.
Dr. Oliver's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1632024: 1555%
- Surgery
- 2023: 112024: 0100%
Where Dr. Oliver's Medicare services took place, 2024
- In an office7649%
- In a facility7951%
Dr. Oliver's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Oliver?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Oliver and other gynecologic oncologists in Rhode Island.
Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data
Dr. Matthew T. Oliver treated 98 Medicare patients in 2024, average age 73
CMS counts 98 Medicare patients who saw Dr. Oliver in 2024. The largest group is 75 to 84, with 43 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Oliver's median patient age at 70, with 99% women.
Dr. Oliver's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Oliver's Medicare patients, 2024
- High cholesterol75%
- High blood pressure74%
- Cancer55%
- Arthritis47%
- Anxiety41%
- Mood disorders33%
- Chronic kidney disease30%
- Depression30%
Share of Medicare patients with each condition. A patient can have several.
Dr. Oliver's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women99%
- Men0%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Matthew T. Oliver wrote 66 Medicare Part D claims in 2024
In 2024, Dr. Oliver wrote 66 Medicare Part D claims for 19 patients. 53% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $397,158 in total drug cost. In 2023, CMS named 12 claims across 1 drug.
Dr. Oliver's Part D claims by kind of drug, 2024
- Generic35 claims53%
- Brand-name31 claims47%
Dr. Oliver's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 122024: 29142%
Drugs named by CMS: 2 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Matthew T. Oliver ranks in the 87th percentile for removal of the uterus in Medicare
Dr. Oliver accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of removal of the uterus by Dr. Oliver, more than 87% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
Where Dr. Oliver ranks in Medicare procedure volume
- Removal of the uterus
- 87th percentile13 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Matthew T. Oliver has 10 publications on record
Dmand AI links 10 papers to Dr. Oliver, published from 2013 to 2025. 2013 was the busiest year, with 2. The most frequent topics are Ovarian Neoplasms, Cell Proliferation and Gene Products, env. Dr. Oliver has published most often in Cell Signal. Dr. Oliver's most frequent co-authors are Paul Andrew Disilvestro, MD, Cara A. Mathews, MD and Lindsey B. Beffa, MD.
Dr. Oliver's papers by year, 2013 to 2025
Topics Dr. Oliver writes about most
- Ovarian Neoplasms
- Cell Proliferation
- Gene Products, env
- Placenta
- Pregnancy Proteins
- RNA, Small Interfering
- Trophoblasts
- Tumor Microenvironment
Dr. Oliver's most frequent co-authors
- Paul Andrew Disilvestro, MD7 shared papers
- Cara A. Mathews, MD3 shared papers
- Lindsey B. Beffa, MD2 shared papers
Recent publications by Dr. Oliver
Gynecol Oncol
Int J Gynecol Cancer
See who Dr. Oliver researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Oliver works with, so you can find a warm path to the right gynecologic oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Matthew T. Oliver has worked on 4 clinical trials
Dmand AI links Dr. Oliver to 4 clinical trials, 2 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Ovarian Epithelial, Esthesioneuroblastoma, Olfactory and Uterine Cervical Neoplasms.
Clinical trials with Dr. Oliver by phase
- 2Phase 1: 2 trials
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Oliver's trials
- Carcinoma, Ovarian Epithelial
- Esthesioneuroblastoma, Olfactory
- Uterine Cervical Neoplasms
- Fallopian Tube Diseases
- Olfactory Nerve Diseases
Investigators on the most trials with Dr. Oliver
- Charles Kellogg Anderson, MD2 shared trials
- Noelle Gillette Cloven, MD2 shared trials
- Lainie P. Martin, MD2 shared trials
Recent clinical trials with Dr. Oliver
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS (opens in a new tab)
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Matthew T. Oliver received $2,801 in industry payments from 2017 to 2024
CMS Open Payments shows 32 general payments to Dr. Oliver from 5 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 66% of the total. Stryker Corporation paid the most, $1,250.
General payments to Dr. Oliver by program year, 2017 to 2024
General payments to Dr. Oliver by kind, 2017 to 2024
- Travel and lodging$1,84066%
- Food and beverage$96134%
Companies that paid Dr. Oliver the most, 2017 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Matthew T. Oliver graduated from East Tennessee State University Quillen College of Medicine
Dr. Oliver graduated from East Tennessee State University Quillen College of Medicine in 2011.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Matthew T. Oliver's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Matthew T. Oliver
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Matthew T. Oliver's NPI number?
Dr. Matthew T. Oliver's NPI number is 1295028611. It was assigned on May 18, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Matthew T. Oliver?
Dr. Matthew T. Oliver is a gynecologic oncologist in Providence, Rhode Island. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).
Where does Dr. Matthew T. Oliver practice?
Dr. Oliver practices at 101 Dudley Street, Providence, RI 02905. Dr. Oliver's primary practice is Women & Infants Hospital of Rhode Island in Providence, Rhode Island, part of Care New England Health System. Dmand AI also links Dr. Oliver to 2 hospitals and 1 medical group.
What is Dr. Matthew T. Oliver's office phone number?
The practice phone on file for Dr. Oliver is (401) 274-1100.
What is Dr. Matthew T. Oliver's medical license number?
Dr. Oliver holds Rhode Island license MD14914, one of the licenses on file in 2 states.
Which states has Dr. Matthew T. Oliver been licensed in?
Dmand AI has state licenses on file for Dr. Oliver in Rhode Island and Massachusetts.
Which hospitals is Dr. Matthew T. Oliver affiliated with?
Dr. Oliver practices at Women & Infants Hospital of Rhode Island in Providence, Rhode Island. Dr. Oliver is also affiliated with Charlton Memorial Hospital. Dmand AI links Dr. Oliver to 2 more hospitals.
What medical group is Dr. Matthew T. Oliver part of?
Dr. Oliver is linked to Care New England Medical Group. Dmand AI links Dr. Oliver to 1 more medical group.
Does Dr. Matthew T. Oliver accept Medicare?
Yes. CMS data shows Dr. Oliver billed Medicare for 155 services in 2024, and Dr. Oliver accepts Medicare assignment.
How many Medicare patients does Dr. Matthew T. Oliver see?
CMS counts 98 Medicare patients who saw Dr. Oliver in 2024, with an average age of 73.
Show 7 more questionsShow fewer questions
What services does Dr. Matthew T. Oliver bill to Medicare?
In 2024, Dr. Oliver's most billed Medicare services were office visit, established patient (99214), care management and other visits (99459) and office visit, new patient (99205).
Where did Dr. Matthew T. Oliver go to medical school?
Dr. Oliver graduated from East Tennessee State University Quillen College of Medicine in 2011.
What drugs does Dr. Matthew T. Oliver prescribe most?
In 2024 Medicare Part D data, Dr. Oliver's most prescribed drugs by claims were Lenvima and Levothyroxine Sodium.
Has Dr. Matthew T. Oliver received payments from drug or device companies?
CMS Open Payments shows $2,801 in general payments to Dr. Oliver from 5 companies from 2017 to 2024. The largest total came from Stryker Corporation.
How long has Dr. Matthew T. Oliver been practicing?
Dr. Oliver graduated from medical school in 2011, 15 years ago.
Does Dr. Matthew T. Oliver do research?
Dmand AI links 10 publications to Dr. Oliver, published from 2013 to 2025. Dr. Oliver has worked on 4 clinical trials.
Who does Dr. Matthew T. Oliver publish with?
Dr. Oliver's most frequent co-authors are Paul Andrew Disilvestro, MD (7 shared papers), Cara A. Mathews, MD (3 shared papers) and Lindsey B. Beffa, MD (2 shared papers).
Selling to gynecologic oncology practices?
See gynecologic oncologists in Rhode Island by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card